Literature DB >> 11176179

The impact of adverse patient occurrences on hospital costs in the pediatric intensive care unit.

T E Dominguez1, R Chalom, A T Costarino.   

Abstract

OBJECTIVES: To study the influence of adverse patient occurrences defined as airway complication (AC), vascular complication (VC), and infectious complication (IC) on intensive care unit (ICU) costs and length of stay (LOS).
DESIGN: Retrospective, cohort study
SETTING: An urban, tertiary care children's hospital in Philadelphia, PA. PATIENTS: All children admitted to a multidisciplinary pediatric ICU during the fiscal year 1994.
INTERVENTIONS: None
MEASUREMENTS AND MAIN RESULTS: Demographic data, diagnoses, Pediatric Risk of Mortality scores, LOS, and deaths were recorded. Hospital charges were converted into costs by using cost-to-charge ratios. There were 23 AC, 35 VC, and 40 IC events. Multiple regression in models adjusting for age, Pediatric Risk of Mortality score, mortality, chronic disease, and diagnosis by using AC, VC, and IC indicator variables was performed on the dependent variables of LOS and total costs. IC was associated with an increase in total costs of $50,361.89 (p < .001), an increased LOS of 15.6 days (p < .001), and no significant increase in daily costs. There were no significant increases in costs or LOS seen with the AC and VC variables. In a matched analysis, the total costs attributable to IC averaged $32,040 per patient.
CONCLUSIONS: The occurrence of complications in the pediatric ICU is associated with meaningful increases in LOS and hospital costs. ICs are more important predictors of costs than ACs or VCs. Continuing efforts should be made to minimize adverse occurrences to improve patient care and reduce costs.

Entities:  

Mesh:

Year:  2001        PMID: 11176179     DOI: 10.1097/00003246-200101000-00033

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

Review 1.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

2.  Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study.

Authors:  M Angeles García-Teresa; Juan Casado-Flores; M Angel Delgado Domínguez; Jorge Roqueta-Mas; Francisco Cambra-Lasaosa; Andrés Concha-Torre; Cristina Fernández-Pérez
Journal:  Intensive Care Med       Date:  2007-01-19       Impact factor: 17.440

3.  Impact of the 2003 ACGME Resident Duty Hour Reform on Hospital-Acquired Conditions: A National Retrospective Analysis.

Authors:  Timothy Wen; Frank J Attenello; Steven Y Cen; Alexander A Khalessi; May Kim-Tenser; Nerses Sanossian; Steven L Giannotta; Arun P Amar; William J Mack
Journal:  J Grad Med Educ       Date:  2017-04

4.  Cost Associated With Pediatric Delirium in the ICU.

Authors:  Chani Traube; Elizabeth A Mauer; Linda M Gerber; Savneet Kaur; Christine Joyce; Abigail Kerson; Charlene Carlo; Daniel Notterman; Stefan Worgall; Gabrielle Silver; Bruce M Greenwald
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

5.  Disruption of the microbiota across multiple body sites in critically ill children.

Authors:  Matthew B Rogers; Brian Firek; Min Shi; Andrew Yeh; Rachel Brower-Sinning; Victoria Aveson; Brittany L Kohl; Anthony Fabio; Joseph A Carcillo; Michael J Morowitz
Journal:  Microbiome       Date:  2016-12-29       Impact factor: 14.650

6.  Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007.

Authors:  Ji-Guang Ding; Qing-Feng Sun; Ke-Cheng Li; Ming-Hua Zheng; Xiao-Hui Miao; Wu Ni; Liang Hong; Jin-Xian Yang; Zhan-Wei Ruan; Rui-Wei Zhou; Hai-Jiao Zhou; Wen-Fei He
Journal:  BMC Infect Dis       Date:  2009-07-25       Impact factor: 3.090

7.  Cost-effectiveness study of early versus late parenteral nutrition in critically ill children (PEPaNIC): preplanned secondary analysis of a multicentre randomised controlled trial.

Authors:  Esther van Puffelen; Suzanne Polinder; Ilse Vanhorebeek; Pieter Jozef Wouters; Niek Bossche; Guido Peers; Sören Verstraete; Koen Felix Maria Joosten; Greet Van den Berghe; Sascha Cornelis Antonius Theodorus Verbruggen; Dieter Mesotten
Journal:  Crit Care       Date:  2018-01-15       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.